Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations

NCT02676843 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT02676843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02676843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2016
Completion date
November 25, 2018
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frontotemporal dementia (ftd), frontotemporal lobar degeneration (ftld), tauopathies